A shared journey through breast cancer: Samantha Duke and Jane Hanson - Insights
When Samantha Duke discovered she had breast cancer, she didn’t have to look far for support. Her mother Jane walked a similar path 16 years earlier. Inspired both by her mom and the strong network of healthcare physicians and professionals...
Sarcoma Informative Cases - Insights
Case #1 Case #2 Case #3 Case #4 Case #5 Sarcomas are malignant tumors that arise in the bone and soft tissue. With numerous subtypes of sarcoma that can
As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.
What's New in Health Care Reform: Jan. 23 - Insights
Top highlights include: Physician burnout now essentially a public health crisis, Americans more likely to die from opioid overdose than in a car accident, study identifies biomarkers to stratify patients for prostate cancer treatment, the...
What's New in Health Care Reform: Jan. 30 - Insights
Top highlights include: Alcohol overtakes Hepatitis C as the top reason for liver transplants, new research call vitamin D benefits into question, NIH funds first artificial pancreas study in the United States for pregnant women, cervical...
Finding the Balance: Legal Issues Arising from Precision Medicine - Insights
By taking into account an individual’s genes, lifestyle, and environment, precision medicine offers the prospect of finding individualized therapies that might ultimately cure diseases such as cancer and diabetes. Yet, as with other...
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Staffing to Workload in Phlebotomy Areas: Direct Effort - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on direct effort through time spent with a patient or patient sample.
A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four...
Jeff Meeusen, Ph.D., Provides Clinical Update on Ceramides - Insights
Jeff Meeusen, Ph.D., Co-Director of Cardiovascular Laboratory Medicine in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, provides a clinical update on ceramides.